Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Kristina Burow - aVenture Research

Kristina Burow

AddedMar 31, 2024

UpdatedOct 12, 2026

Kristina Burow

Kristina Burow

Board Member, AgTech Accelerator

Kristina Burow's Career

AgTech Accelerator

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment Firm

Triangle (historical), NC, US

Board Member· Board

Scholar Rock Holding

Cambridge, MA, US

Board Member· Board

Vir Biotechnology

Public$908.6MSan Francisco, CA, US

Board Member· Board

Beam Therapeutics

Public$689MCambridge, MA, US

Board Member· Board

Limerick BioPharma

$47.1MSouth San Francisco, CA, US

Board Member· Board

Pretzel Therapeutics

Series A$72.5MWaltham, MA, US

Board Member· Board

Kilimanjaro Energy

Series A$2.3MWaukesha, WI, US

Board Member· Board

Boragen

Series A$15.3MDurham, NC, US

Board Member· Board

BlackThorn Therapeutics

$138MSan Francisco, CA, US

Board Member· Board

Rome Therapeutics

Boston, MA, US

Board Member· Board

Orbital Therapeutics

$1.8BCambridge, MA, US

Board Member· Board

AgBiome

Series D$252.5MTriangle (historical), NC, US

Board Member· Board

Vividion Therapeutics

$371.5MSan Diego, CA, US

Board Member· Board

Sapphire Energy

$376.5MSan Diego, CA, US

Board Member· Board

People Similar to Kristina Burow

Bob LangerCo-Founder · SQZ Biotechnologies

Dr John RyalsBoard Member · AgBiome

Misti UshioBoard Member · Ancora Pharmaceuticals

Jeff HatfieldBoard Member · Vir Biotechnology

John MaraganoreExecutive Chair · City Therapeutics

Leadership at AgTech Accelerator

Byron SmithBoard Member

Joseph Cook Jr "Joe"Board Member

Similar to AgTech Accelerator

Iowa AgriTech AcceleratorDes Moines, IA, USest. 2017Iowa AgriTech AcceleratorDes Moines, IA, US · est. 2017

Iowa-based AgriTech Accelerator: Mentor-led platform for innovative AgTech startups.

Investment Firm7

HudsonAlpha AgTechMadison, WI, USest. 2022HudsonAlpha AgTechMadison, WI, US · est. 2022

Madison-based HudsonAlpha AgTech Accelerator empowers agri-tech startups with coaching, financing, and connections.

Investment Firm50

Ag Innovation Development GroupMemphis, TN, USest. 2013Ag Innovation Development GroupMemphis, TN, US · est. 2013

Ag Innovation Development Group: Commercializing early-stage agri-tech for efficient farming and investor returns.

Investment Firm7

Ag Startup EngineAmes, IA, USest. 2015Ag Startup EngineAmes, IA, US · est. 2015

Ag Startup Engine: A US-based venture capital firm investing in early-stage ag-tech entrepreneurs, offering mentorship and financial support.

Investment Firm6

Leadership at Limerick BioPharma

Wendye RobbinsBoard Member

Steve DowBoard Member

Similar to Limerick BioPharma

NGM BiopharmaceuticalsSouth San Francisco, CA, USTherapeuticsest. 2007NGM BiopharmaceuticalsSouth San Francisco, CA, US · est. 2007

NGM Biopharmaceuticals: A clinical-stage company developing novel therapeutics for various diseases in the US.

Public · $420.4M225

Lipidio PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2018Lipidio PharmaceuticalsSan Diego, CA, US · est. 2018

Lipidio Pharma: Advancing molecules for dermatological and metabolic diseases treatment.

Series A · $20M5

LipimetiXNatick, MA, USPharmaceuticalsest. 2012LipimetiXNatick, MA, US · est. 2012

LipimetiX Development, a biopharmaceutical JV, develops novel drugs for cholesterol-related diseases using peptide mimetics technology.

Pre-Seed · $1M5

ComplexaPittsburgh, PA, USTherapeuticsest. 2008ComplexaPittsburgh, PA, US · est. 2008

Complexa, Inc.: A biopharmaceutical firm innovating therapies for inflammatory and metabolic diseases.

Public · $86.9M7

Leadership at Vir Biotechnology

Phillip A. SharpBoard Member

Elliott SigalBoard Member

Rob PerezBoard Member

Louis PickerCo-Founder

Klaus FruehCo-Founder

George ScangosBoard Member

Similar to Vir Biotechnology

Virion TherapeuticsNewark, DE, USImmunotherapy, Vaccinesest. 2018Virion TherapeuticsNewark, DE, US · est. 2018

Virion Therapeutics: A global biotech firm innovating vaccines for cancers and chronic viral infections.

Series A · $14.1M8

Leadership at Beam Therapeutics

John EvansBoard Member

Graham CooperBoard Member

J. Keith JoungCo-Founder

Feng ZhangCo-Founder

Carole HoBoard Member

Similar to Beam Therapeutics

Editas MedicineCambridge, MA, USGene Editing, Therapiesest. 2013Editas MedicineCambridge, MA, US · est. 2013

Editas Medicine, Inc.: A clinical-stage biotech firm pioneering CRISPR-based therapies for rare diseases.

Public · $931.6M226

Leadership at Pretzel Therapeutics

Christina Trojel-Hansen PhDCo-Founder

Jay ParrishBoard Member

Alaa HalawaBoard Member

Robert TansleyBoard Member

Michal MinczukCo-Founder

Similar to Pretzel Therapeutics

Lucy TherapeuticsCambridge, MA, USDrug Discoveryest. 2017Lucy TherapeuticsCambridge, MA, US · est. 2017

Lucy Therapeutics: Innovating drug discovery with a unique focus on early disease pathogenesis.

Series B · $23.1M14

Leadership at Kilimanjaro Energy

Klaus LacknerCo-Founder

Ned DavidCo-Founder

Similar to Kilimanjaro Energy

SusteonCary, NC, USCarbon Captureest. 2018SusteonCary, NC, US · est. 2018

Susteon: Pioneering carbon dioxide capture tech, directly targeting large emission sources.

Angel · $806k14

Holy GrailMountain View, CA, USCarbon Captureest. 2019Holy GrailMountain View, CA, US · est. 2019

Holy Grail: Capturing CO2 from air for sustainability and energy storage.

Mova TechnologiesPulaski, VA, USClean Energyest. 2010Mova TechnologiesPulaski, VA, US · est. 2010

MOVA Technologies: Enhancing efficiency in carbon-based fuel facilities for cleaner energy.

Pre-Seed · $1.3M11

AirMyneBerkeley, CA, USCarbon Captureest. 2022AirMyneBerkeley, CA, US · est. 2022

AirMyne: Capturing & removing CO2 from air at scale, aiding Net Zero goals. Based in Berkeley, CA.

Leadership at Boragen

C. Tony LiuCo-Founder

Lucy ShapiroCo-Founder

Rob ReadnourBoard Member

Gerald FinkCo-Founder

Stephen BenkovicCo-Founder

Similar to Boragen

CropsolutionMorrisville, NC, USAgrochemicals, Crop Protectionest. 2001CropsolutionMorrisville, NC, US · est. 2001

Innovative medical and agrochemical solutions from Morrisville, NC.

Series C · $9.3M50

Leadership at BlackThorn Therapeutics

George GolumbeskiBoard Member

Mark H N CorriganBoard Member

Alex TkachenkoFounder

Paul L. BernsBoard Member

Julie SunderlandBoard Member

Lori HuBoard Member

Similar to BlackThorn Therapeutics

Mahzi TherapeuticsSan Mateo, CA, USBiotechest. 2020Mahzi TherapeuticsSan Mateo, CA, US · est. 2020

Mahzi Therapeutics: A California-based healthcare and biotech firm, founded in 2020.

Series A · $47.3M13

Leadership at Orbital Therapeutics

Carol SuhBoard Member

Giuseppe CiaramellaCo-Founder & CEO

Similar to Orbital Therapeutics

Orna TherapeuticsCambridge, MA, USTherapeuticsest. 2019Orna TherapeuticsCambridge, MA, US · est. 2019

Orna Therapeutics, founded in 2019, is a biotech firm specializing in the design and delivery of engineered circular RNA therapeutics.

ReNAgade TherapeuticsCambridge, MA, USRNA Therapeuticsest. 2021ReNAgade TherapeuticsCambridge, MA, US · est. 2021

ReNAgade Therapeutics: Pioneering RNA-based solutions for disease treatment through innovative medication production.

Series A · $300M123

ReviR TherapeuticsSan Francisco, CA, USMedicines, Therapeuticsest. 2021ReviR TherapeuticsSan Francisco, CA, US · est. 2021

ReviR Therapeutics: A genomics-based platform for developing innovative RNA-targeting medicines.

Arcturus Therapeutics HoldingsSan Diego, CA, USRNA Therapeuticsest. 2019Arcturus Therapeutics HoldingsSan Diego, CA, US · est. 2019

San Diego-based Arcturus Therapeutics Holdings Inc. specializes in RNA therapeutics for disease treatment.

Leadership at AgBiome

Scott UknesCo-Founder

John RyalsCo-Founder

Marijn DekkersBoard Member

Alison LawtonBoard Member

Amir NashatBoard Member

Jeff DanglCo-Founder

Similar to AgBiome

Ascribe BioscienceIthaca, NY, USCrop Protectionest. 2017Ascribe BioscienceIthaca, NY, US · est. 2017

Ascribe Bioscience: Developing eco-friendly products to boost crop defenses against pathogens since 2017.

Leadership at Vividion Therapeutics

John ClarkeBoard Member

Phil BaranCo-Founder

Paul SchimmelBoard Member

Tom WoiwodeBoard Member

Jin-Quan YuCo-Founder

Aleksandra RizoBoard Member

Similar to Vividion Therapeutics

Vivace TherapeuticsSan Mateo, CA, USDrug Developmentest. 2014Vivace TherapeuticsSan Mateo, CA, US · est. 2014

Vivace Therapeutics: A venture-backed, oncology-focused drug discovery and development firm in San Mateo, CA.

Series C · $70M30

Leadership at Sapphire Energy

Robert ShapiroBoard Member

Nathaniel DavidFounder

Steve GoldbyBoard Member

Cynthia WarnerCEO

Robert NelsenBoard Member

Similar to Sapphire Energy

SGP BioenergyNew York City, NY, USBioenergy, BiofuelSGP BioenergyNew York City, NY, US

SGP BioEnergy: Developing and producing integrated bioenergy products for a sustainable future.

ViriomSan Diego, CA, USHBV Treatments, HIV Treatmentsest. 2009

ViriomSan Diego, CA, US · est. 2009

Viriom: A therapeutic biotech firm innovating treatments for HIV and Hepatitis B.

Series B · $35.4M200

TherabiolSan Francisco, CA, USImmune Therapiesest. 2012TherabiolSan Francisco, CA, US · est. 2012

Therabiol, Inc.: A San Francisco-based biotech firm specializing in developing immune therapies for viral infections.

Precision VirologicsSt. Louis, MO, USBiotechest. 2016Precision VirologicsSt. Louis, MO, US · est. 2016

Precision Virologics: A St. Louis-based biotech startup innovating in virology.

Intellia TherapeuticsCambridge, MA, USGene Editing, Therapiesest. 2014

Intellia TherapeuticsCambridge, MA, US · est. 2014

Cambridge-based Intellia Therapeutics pioneers gene editing therapies for genetic diseases.

Public · $1.2B598

Nvelop TherapeuticsCambridge, MA, USGene Editingest. 2022Nvelop TherapeuticsCambridge, MA, US · est. 2022

Cambridge-based Nvelop Therapeutics offers gene editing solutions for major unmet disease needs.

Seed · $100M12

Precision BioSciencesDurham, NC, USCancer Treatmentest. 2006Precision BioSciencesDurham, NC, US · est. 2006

US-based Precision Biosciences, Inc. is a biotech firm specializing in cancer treatment solutions.

Public · $225.2M198

Mitochon PharmaceuticalsRadnor, PA, USDrug Developmentest. 2014

Mitochon PharmaceuticalsRadnor, PA, US · est. 2014

Mitochon Pharmaceuticals: A biotech start-up developing targeted drugs for serious diseases since 2014.

Seed · $2.3M4

Stealth BioTherapeuticsNeedham, MA, USTherapiesest. 2007Stealth BioTherapeuticsNeedham, MA, US · est. 2007

US-based Stealth BioTherapeutics develops therapies for genetic mitochondrial and age-related diseases.

Public · $191.4M52

MitoChem TherapeuticsCharleston, SC, USTherapeuticsest. 2011MitoChem TherapeuticsCharleston, SC, US · est. 2011

MitoChem Therapeutics: Pioneering treatments for neurodegenerative diseases through mitochondrial research.

5MetisDurham, NC, USCrop Protectionest. 2021

5MetisDurham, NC, US · est. 2021

5Metis: A pioneering crop health discovery firm, merging boron-based molecules and synthetic biology.

Series A · $10M14

VM AgritechGeneva, NY, USFungicidesest. 2014VM AgritechGeneva, NY, US · est. 2014

VM Agritech: Providing eco-friendly, broad-spectrum fungicides with non-resistant action.

Series A · $7.6M3

FortiphyteBerkeley, CA, USAgricultural Productsest. 2017FortiphyteBerkeley, CA, US · est. 2017

Fortiphyte, founded in 2017, provides agricultural protection products to safeguard crops and minimize fungicide use.

Chase TherapeuticsWashington, D.C., DC, USPharmaceuticalsest. 2017

Chase TherapeuticsWashington, D.C., DC, US · est. 2017

Chase Therapeutics: An early-stage pharmaceutical company innovating superior brain disease treatments.

Series B · $25.3M175

NeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30

Orphan Star TherapeuticsNew York City, NY, USTherapiesest. 2017Orphan Star TherapeuticsNew York City, NY, US · est. 2017

Orphan Star Therapeutics: A NY-based biopharmaceutical firm developing therapies for rare diseases.

Series B · $20M5

AgrynexIthaca, NY, USBiopesticides, Crop Protectionest. 2015

AgrynexIthaca, NY, US · est. 2015

Agrynex: Providing biocidal enzymes for crop protection against soil-borne diseases.

$50k4

BioConsortiaDavis, CA, USBiofertilizers, Crop Protectionest. 2014BioConsortiaDavis, CA, US · est. 2014

BioConsortia Inc.: An agri-biotech firm enhancing fertilizer efficiency, plant growth, and crop breeding.

Series D · $67M45

Adaptive Symbiotic TechnologiesSeattle, WA, USAgricultural Productsest. 2011Adaptive Symbiotic TechnologiesSeattle, WA, US · est. 2011

Seattle-based biotech firm specializing in symbiotic plant microbes for enhanced crop yield.

Series A · $4.5M17

Synnovation TherapeuticsWilmington, DE, USOncology Therapiesest. 2021

Synnovation TherapeuticsWilmington, DE, US · est. 2021

Synnovation Therapeutics: Precision oncology firm specializing in small molecule therapies for cancer.

Series A · $139M18

Tavros TherapeuticsDurham, NC, USOncology Therapeuticsest. 2019Tavros TherapeuticsDurham, NC, US · est. 2019

Tavros Therapeutics: A Durham-based biotech firm specializing in precision oncology since 2019.

Series B · $28M17

Belharra TherapeuticsSan Diego, CA, USDrug Discoveryest. 2021Belharra TherapeuticsSan Diego, CA, US · est. 2021

Belharra Therapeutics: Innovating drug discovery with a unique photoaffinity-based chemoproteomics platform.

Series A · $50M64

Sapphire TechnologiesCerritos, CA, US

Energy Recovery Systemsest. 2021

Sapphire TechnologiesCerritos, CA, US · est. 2021

Sapphire Technologies: Leading manufacturer of energy recovery systems for gas and hydrogen applications.

Series B · $10M23

Renewable Fuel ProductsBiomass, Renewable Energyest. 2007Renewable Fuel Productsest. 2007

Renewable Fuel Products, Inc: A startup pioneering in renewable energy alternatives and algae biomass systems.

Keyspan EnergyMelville, NY, USEnergy Servicesest. 1998Keyspan EnergyMelville, NY, US · est. 1998

Leading green energy provider using bio-fuel.

Public · $200k2.8k